Oramed Pharmaceuticals (ORMP) Tmuɣli n wazal
Ṛṛbem n lḥedd$4.74Yettwalemmaḍ 25 Sep 2026 19:59 UTC
Beddel-0.84%
Asnulfu n AI: ORMP
AI tessawal ɣef timaqsiṭ n wazal i wass n tnekkit d-iteddun, taggara n yimal akked taggara n waggʷas. Asnifel yettwamḍen seg wazal aneggaru. Aya d tinineḍ n tḥisabt, ma tga ara timsisi n usihel.
Asref n 6 isggʷasn ineggura
Premium tessaɣ-d iswiyat n tɣara n AI i wass, amalas d waggʷas n yiwen i uḍris-a akk d yisɣunan niḍen.
Serreḥ Premium🔒 Tazmilt n usenfar
Amezruy n tmuɣliyin — akk tmuɣliyin n zik akked wazal n tnekkit — d akcum n Premium.
Serreḥ PremiumƔef tneɣlaft-a
Oramed Pharmaceuticals is a pharmaceutical company specializing in the development of oral delivery solutions. The company is developing oral insulin capsules for the treatment of diabetes, as well as delivery solutions for other drugs and vaccines.
